Login

Switch On Your HIV Smarts.

An “Improved Backbone” for New HIV Regimens Now Under FDA Review

An “Improved Backbone” for New HIV Regimens Now Under FDA Review

April 9, 2015, by

A new version of tenofovir may result in a better-tolerated replacement for Truvada. Read More

PrEP and Drug Resistance: Cause for Concern?

PrEP and Drug Resistance: Cause for Concern?

April 6, 2015, by

A new study examines HIV drug resistance associated with PrEP, and what it could mean as this highly-effective prevention strategy becomes more prevalent. Read More

Timothy Ray Brown, the Berlin Patient, Accepts Award

Timothy Ray Brown, the Berlin Patient, Accepts Award

April 3, 2015, by

The Berlin Patient recently accepted an award at a San Francisco HIV cure symposium. Find out why he receives special recognition as researchers use his case to learn more about how to cure HIV. Read More

Compound Found to Block HIV Receptors in Monkeys

Compound Found to Block HIV Receptors in Monkeys

April 1, 2015, by

A recent New York Times article explains the science behind a new advance that could contribute to a successful HIV vaccine. Read More

Dolutegravir Shows Promise as Part of First-Line HIV Therapy

Dolutegravir Shows Promise as Part of First-Line HIV Therapy

March 30, 2015, by

An integrase inhibitor fared well in a head-to-head comparison with a protease inhibitor regimen for people just starting ART. Find out why this is surprising and what it could mean for treatment naïve people with high viral loads. Read More